Fig. 2
From: PACAP38-induced migraine attacks are independent of CGRP signaling: a randomized controlled trial
Headache intensity scores. Median headache intensity scores (thick lines) and individual participant headache scores (thin lines) on the numerical rating scale (NRS) following placebo-PACAP-38 (blue) and eptinezumab-PACAP-38 (red) interventions are shown for comparison.